How have the shares performed?
180 Life Sciences Corp. (ATNF) saw downtrend of -4.87% in the recent trading with $10.15 being its most recent. The current price level -22.19% lower than the highest price of $13.05 marked by the stock while trading over the past 52-weeks, whereas it is 434.21% higher than the lowest price of $1.90 the company dropped to over past 52-weeks. The latest news story on ATNF appeared in GlobeNewswire under the title “180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors” on Jun-10-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -13.62% below one month high and is +40.58% above of the lowest during that time. Looking into the simple moving average, 180 Life Sciences Corp. (ATNF)’s stock stands at a SMA-50 of $9.04 while that of 5-day is reading $10.59.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and ATNF’s SMA-200 as of now is $6.89.
180 Life Sciences Corp. Earnings – What Happened With ATNF
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
ATNF – 180 Life Sciences Corp. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 24.13 million. ATNF does have institutional investors; and they hold 7.30% of the stock.
180 Life Sciences Corp. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 3 new insider purchases involving 67,802 shares. On the other hand, ATNF declared 554,695 shares have been sold in 4 insider transactions over the past three months.
As on Mar 30, 2021, Vanguard Group, Inc. (The) was the top most holder in 180 Life Sciences Corp. (NASDAQ:ATNF) with an ownership of 0.5 million shares of the company or 2.78% of the stake worth $3.29 million. The filing also reveals Boothbay Fund Management, LLC as the second largest holder in the company with a control over 2.65% of the outstanding shares. Its stake is worth $3.14 million for having 0.48 million shares in hand.
Blackrock Inc. also came holding a key position in the company during the recent quarter and it now holds 1.43% of the outstanding shares. With this there are now 24 institutions which have possession in ATNF’s shares.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, 180 Life Sciences Corp. has a debt to equity ratio of 0.55.
Technical Analysis of 180 Life Sciences Corp. (NASDAQ:ATNF) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for 180 Life Sciences Corp. (ATNF), we notice that the stock’s 20-day average volume is at 390,045 shares and 50% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 1,953,978 shares. And to end, ATNF’s 100-day average volume is 2,168,798 shares with 100% of the long-term indicators pointing towards Buy for the stock.